RACHEL SMITH: Open Payments
NPI 1336663970 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$262 in 12 payments from 9 companies in 2025. Trend: 2023 $441 · 2024 $196 · 2025 $262
Food & beverage: $262
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $46 |
| Exact Sciences Corporation | 2 | $38 |
| Nalu Medical, Inc. | 1 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
| Corcept Therapeutics | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Abbott Laboratories | 1 | $23 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $16 |
Products named: Nalu Neurostimulation System, Ozempic, JARDIANCE, Korlym, TRELEGY ELLIPTA, FREESTYLE LIBRE 3, AZMIRO, Cologuard Collection Kit.
Industry payments across NV — which companies pay providers there.
